Trademarkia Logo

Canada

C$
IMPLAVAX
REGISTERED

on 21 May 2021

Last Applicant/ Owned by

ENESI PHARMA LIMITED

45B Western AvenueMilton Park, AbingdonOxfordshire OX14 4RU

GB

Serial Number

1889128 filed on 20th Mar 2018

Registration Number

TMA1100602 registered on 21st May 2021

Registration expiry Date

21st May 2031

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

IMPLAVAX

Trademark usage description

pharmaceutical and veterinary preparations and substances for the treatment of and protection against disease namely, pharmaceutical antiallergic prep Read More

Classification Information


Class [005]
Pharmaceutical and veterinary preparations and substances for the treatment of and protection against disease namely, pharmaceutical antiallergic preparations and substances, pharmaceutical cough preparations, pharmaceuticals for the treatment of erectile dysfunction, pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral and injectable contraceptives, thyroid hormone preparations, pharmaceutical preparations and substances for the prevention of cancer, pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, pharmaceutical preparations for reducing cholesterol, pharmaceutical preparations for regulating the immune system, pharmaceutical preparations for suppressing tumours, pharmaceutical preparations for the treatment of autoimmune diseases, pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of cardiovascular diseases, pharmaceutical preparations for the treatment of chronic pain, pharmaceutical preparations for the treatment of cranial or facial nerve disorders, pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis, pharmaceutical preparations for the treatment of diabetes, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, pharmaceutical preparations for the treatment of drug and alcohol abuse, pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, pharmaceutical preparations for the treatment of hypercholesteremia, pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, pharmaceutical preparations for the treatment of multiple sclerosis, pharmaceutical preparations for the treatment of myalgia and neuralgia, pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, pharmaceutical preparations for the treatment of Parkinson's disease, pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction, pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, pharmaceutical preparations for the treatment of smoking cessation, pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical and veterinary preparations and substances for the treatment and prevention of cancers, yellow fever, rabies, diphtheria, tetanus, haemophilus influenza type B (Hib), pertussis, pneumococcal diseases, meningococcal diseases, human papilloma viruses (HPV), HTV,HSV2/HSV1, influenza (types A, B and C), para influenza, coronavirus, polio, RSV, rhinoviruses, rotaviruses, hepatitis A, acquired immunodeficiency syndrome (AIDS), anthrax, gastroenteritis, enterovirus diseases, 5 measles, mumps, varicella zoster, glandular fever, respiratory diseases, rubella, human T-cell lymphoma type I (HTLV-I), hepatitis B, hepatitis C, hepatitis D, poxvirus diseases, cholera, Japanese encephalitis, zika, chikungunya, bat lyssavirus, Q fever, rift valley fever, hendra virus, tularaemia, nipah virus, lassa fever, typhoid fever, Crimean-Congo haemorrhagic fever, ebola, plague and shigella, and against veterinary diseases, namely foot and mouth 10 disease and serotypes O, A, C, SAT-1, SAT-2, SAT-3 and Asia- 1, coronavirus, bluetongue, feline leukaemia virus, avian influenza, hendra and nipah virus, pestivirus, canine parvovirus and bovine viral diarrhoea virus; human and veterinary vaccines, human and veterinary prophylactic vaccines, human and veterinary therapeutic vaccines; contraceptive preparations and substances


Classification kind code

11

Class [010]
Surgical, medical, dental and veterinary apparatus and instruments namely, medical devices for dispensing of pharmaceutical preparations, namely drug and vaccine dosing and dispensing syringes, injector syringes, needle-free injectors, and pens for use in injecting pharmaceutical preparations, a disposable needle cassette and a disposable drug cartridge; medical devices, namely syringes, injector syringes, needlefree injectors and pens for dosing and dispensing of pharmaceutical preparations, needle-free cassettes for use with medical devices, namely syringes, injector syringes, needle-free injectors and pens; medical delivery devices in the form of a syringe, medical fluid injectors, needle-free injectors and pens for injecting a pharmaceutical preparation


Classification kind code

11

Class [042]
Medical and veterinary research and development services, medical and veterinary device development services, pharmaceutical development services, pharmaceutical delivery system development services, preparation and formulation of pharmaceuticals, research into vaccines, medical and veterinary device and product testing services, provision of information relating to the aforesaid services, consultancy in relation to the aforesaid services


Classification kind code

11

Mark Details


Serial Number

1889128

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 24th Feb 2021
Advertised
Submitted for opposition 26
on 28th Jan 2021
Approved
Submitted for opposition 27
on 28th Jan 2021
Approval Notice Sent
Submitted for opposition 15
on 21st Aug 2020
Correspondence Created
Submitted for opposition 12
on 23rd Jul 2020
Extension of Time
Submitted for opposition 22
on 8th Aug 2019
Search Recorded
Submitted for opposition 20
on 8th Aug 2019
Examiner's First Report
Submitted for opposition 31
on 26th Mar 2018
Formalized
Submitted for opposition 1
on 21st Mar 2018
Created
Submitted for opposition 30
on 20th Mar 2018
Filed